Vitamin A
Drug - Vitamin A
The trade name of the product as shown on the labeling.
Dosage -
CAPSULE; ORAL
The product dosage form and route separated by a semi-colon.
Active Ingredient(s) -
Vitamin A Palmitate
Multiple ingredients are in alphabetical order.
Strength -
EQ 50,000 UNITS BASE
The potency of the active ingredient(s), Vitamin A Palmitate. May repeat for multiple part products.
Applicant -
CHASE CHEM
The firm name holding legal responsibility for Vitamin A. The firm name is condensed to a maximum twenty character unique string.
New Drug Application (NDA) Number -
080746
The FDA assigned number to Vitamin A. Format is nnnnnn.
Product Number -
001
The FDA assigned number to identify Vitamin A. Each strength is a separate product. May repeat for multiple part products. Format is nnn.
Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.
Approval Date -
Approved Prior to Jan 1, 1982
The date Vitamin A was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".
Reference Listed Drug (RLD) -
No
The pioneer or innovator of Vitamin A. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.
Type -
DISCN
The group or category of approved drugs Vitamin A is in. Format is RX, OTC, DISCN.
Applicant Full Name -
Chase Chemical Co Lp
The full name of the firm holding legal responsibility for the new application of Vitamin A.
Vitamin A
Vitamin A Eq 50,000 Units Base Capsule; Oral Vitamin A Eq 50,000 Units Base Capsule; Oral Vitamin A 50,000 Iu Capsule; Oral Vitamin A 50,000usp Units Capsule; Oral Vitamin A 50,000usp Units Capsule; Oral Afaxin Eq 50,000 Units Base Capsule; Oral Alphalin Eq 50,000 Units Base Capsule; Oral Del-vi-a Eq 50,000 Units Base Capsule; Oral Vi-dom-a Eq 50,000 Units Base Capsule; Oral Vitamin A Eq 50,000 Units Base Capsule; Oral
NewDrugInformation
|